查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1789371

眼科溶液市場：按類型、治療用途、藥物類別、防腐劑、類型、劑型、黏度、分銷管道、最終用戶和地區分類

Eye Drops Market, By Type, By Therapeutic Application, By Drug Class, By Preservative Status, By Type, By Formulation, By Viscosity, By Distribution Channel, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年眼藥水市場價值將達到 68.1 億美元，到 2032 年將達到 92.7 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 4.2%。

分析範圍 分析詳細資訊
基準年 2024 市場規模（2025年） 68.1億美元
效能數據 2020-2024 預測期 2025-2032
預測期間的複合年成長率（2025-2032年） 4.20% 預計金額（2032年） 92.7億美元

全球眼藥水市場是眼科製藥行業的一個重要領域，涵蓋了旨在治療各種眼科疾病和保持最佳眼部健康的廣泛治療和診斷解決方案。

眼藥水，又稱眼藥水，是針對青光眼、乾眼症、過敏性結膜炎、細菌和病毒感染疾病、發炎相關疾病等藥物的主要傳遞機制。該市場包括處方藥、非處方藥、人工淚液、抗組織胺、抗生素、抗發炎藥物以及青光眼藥物等特殊製劑。

隨著人口老化、長時間使用螢幕、環境污染以及生活方式的改變等因素導致眼部疾病的盛行率不斷上升，全球對有效眼部護理的需求持續成長。藥物輸送系統的技術進步、創新的無防腐劑配方以及能夠提高患者依從性和治療效果的緩釋性機制的開發，進一步推動了市場的成長軌跡。

市場動態

全球眼藥水市場受多種關鍵因素驅動，這些因素推動了其在國際市場的擴張。隨著老齡化老化，青光眼、黃斑部病變、糖尿病視網膜病變等與年齡相關的疾病正影響著全球數百萬人。此外，數位設備使用的快速成長導致電腦視覺症候群和乾眼症的發生率激增，對潤滑和治療性眼藥水的需求也隨之激增。

藥物輸送系統的技術創新，例如無防腐劑配方和緩釋性機制，正在改善患者的依從性和治療效果，進一步推動市場成長。然而，也存在一些重大因素阻礙市場擴張潛力。眼科產品的嚴格監管要求需要大量的臨床試驗和核准流程，這導致漫長的開發週期和巨大的資金投入，這對中小型製造商來說可能是一個障礙。

此外，眼藥水中某些防腐劑的污染和副作用風險也引發了患者和醫護人員的安全疑慮。知名品牌產品的專利到期也加劇了競爭壓力，降低了製藥公司的利潤率。儘管面臨這些挑戰，眼藥水市場仍蘊藏著巨大的成長與創新機會。此外，由於醫療基礎設施的改善和眼部健康意識的不斷提升，亞太和拉丁美洲的新興市場也蘊藏著尚未開發的潛力。

本報告的主要特點

  • 本報告對全球眼科溶液市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
  • 它還強調了每個領域的潛在商機，並描述了該市場的一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球眼藥水市場的主要企業已根據公司概況、產品系列、主要亮點、財務績效和策略等參數進行了分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
  • 「全球眼藥水市場」報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球眼藥水市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 分析目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 抑制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 企業合併（M&A）場景
  • 產業趨勢

第4章 全球眼科解決方案市場（按類型）（2020-2032）

  • 處方箋眼藥水
  • 非處方眼藥水

5. 全球眼科解決方案市場依治療用途分類（2020-2032）

  • 乾眼症（DED）管理
  • 過敏性結膜炎的治療
  • 青光眼和眼高壓
  • 治療眼部感染疾病（細菌、病毒、黴菌）
  • 發炎或術後護理
  • 瞳孔散大或睫狀肌麻痺
  • 診斷染料溶液
  • 術後照護（局部麻醉）
  • 葡萄膜炎
  • 其他視網膜疾病

6. 全球眼科解決方案市場（按藥品類別分類）（2020-2032 年）

  • 潤滑劑和潤膚劑
  • 抗組織胺藥
  • 肥大細胞穩定劑
  • 皮質類固醇
  • 非類固醇消炎劑（NSAID）
  • 前列腺素類似物
  • BETA受體阻斷劑
  • α-促效劑
  • 碳酸酐酶抑制劑
  • 抗生素
  • 抗病毒藥物
  • 抗真菌藥物
  • 血管收縮劑
  • 伴隨用藥

7. 全球眼科解決方案市場（依防腐劑分類）（2020-2032）

  • 含防腐劑的眼藥水
  • 不含防腐劑的眼藥水

第 8 章 全球眼科解決方案市場（按類型）（2020-2032 年）

  • 品牌
  • 學名藥

9. 全球眼科解決方案市場（按劑型分類）（2020-2032 年）

  • 解決方案
  • 暫停
  • 乳劑

第 10 章 全球眼科解決方案市場（按黏度）（2020-2032 年）

  • 低黏度
  • 中等黏度
  • 高黏度

第 11 章 全球眼科解決方案市場按通路分類（2020-2032 年）

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 12 章 全球眼科解決方案市場（按最終用戶分類）（2020-2032 年）

  • 醫院
  • 眼科診所
  • 其他（門診手術中心）

第 13 章 按地區分類的全球眼科解決方案市場（2020-2032 年）

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第14章競爭格局

  • Alcon
  • AbbVie Inc（Allergan）
  • Bausch Health Companies Inc
  • Johnson & Johnson Vision
  • Santen Pharmaceutical Co Ltd
  • Pfizer Inc
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd
  • Otsuka Pharmaceutical Co Ltd
  • Rohto Pharmaceutical Co Ltd
  • Thea Pharma Inc
  • Similasan Corporation
  • Akorn Operating Company LLC
  • Prestige Consumer Healthcare Inc
  • Jamjoom Pharmaceuticals

第15章 分析師建議

  • “命運之輪”
  • 分析師觀點
  • Coherent Opportunity Map (COM)

第16章參考文獻與調查方法

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI8253

Eye Drops Market is estimated to be valued at USD 6.81 Bn in 2025 and is expected to reach USD 9.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.81 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.20% 2032 Value Projection: USD 9.27 Bn

The global eye drops market represents a critical segment of the ophthalmic pharmaceutical industry, encompassing a diverse range of therapeutic and diagnostic solutions designed to address various ocular conditions and maintain optimal eye health.

Eye drops, also known as ophthalmic solutions, serve as the primary delivery mechanism for medications targeting conditions such as glaucoma, dry eye syndrome, allergic conjunctivitis, bacterial and viral infections, and inflammation-related disorders. The market encompasses prescription medications, over-the-counter solutions, and specialized formulations including artificial tears, antihistamines, antibiotics, anti-inflammatory agents, and glaucoma medications.

With the increasing prevalence of eye-related disorders driven by factors such as aging populations, prolonged screen time, environmental pollutants, and lifestyle changes, the demand for effective ophthalmic treatments continues to escalate globally. The market's growth trajectory is further supported by technological advancements in drug delivery systems, innovative preservative-free formulations, and the development of sustained-release mechanisms that enhance patient compliance and therapeutic efficacy.

Market Dynamics

The global eye drops market is propelled by several key drivers that collectively fuel its expansion across international markets. The primary growth driver stems from the rising prevalence of ocular disorders, particularly age-related conditions such as glaucoma, macular degeneration, and diabetic retinopathy, which affect millions of individuals worldwide as populations continue to age. Additionally, the exponential increase in digital device usage has led to a surge in computer vision syndrome and dry eye conditions, creating substantial demand for lubricating and therapeutic eye drops.

Technological innovations in drug delivery systems, including preservative-free formulations and extended-release mechanisms, enhance patient compliance and treatment outcomes, further driving market growth. However, the market faces significant restraints that challenge its expansion potential. Stringent regulatory requirements for ophthalmic products necessitate extensive clinical trials and approval processes, resulting in lengthy development timelines and substantial financial investments that may deter smaller manufacturers.

Furthermore, the risk of contamination and adverse reactions associated with certain preservatives in eye drops raises safety concerns among patients and healthcare providers. Patent expirations of major branded products also intensify competitive pressures and reduce profit margins for pharmaceutical companies. Despite these challenges, the market presents substantial opportunities for growth and innovation. The expanding geriatric population globally creates a sustained demand for ophthalmic treatments, while emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and rising awareness about eye health.

Key Features of the Study

  • This report provides in-depth analysis of the global eye drops market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include major pharmaceutical manufacturers, Alcon, AbbVie Inc (Allergan), Bausch Health Companies Inc, Johnson & Johnson Vision, Santen Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Sun Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd, Thea Pharma Inc, Similasan Corporation, Akorn Operating Company LLC, Prestige Consumer Healthcare Inc, and Jamjoom Pharmaceuticals.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye drops market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription Eye Drops
    • Over-the-Counter (OTC) Eye Drops
  • Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Dry Eye Disease (DED) Management
    • Allergic Conjunctivitis Treatment
    • Glaucoma & Ocular Hypertension
    • Eye Infection Treatment (Bacterial, Viral, Fungal)
    • Inflammation or Post-Surgical Care
    • Mydriasis or Cycloplegia
    • Diagnostic Dye Solutions
    • Post-Operative Care (Anesthetic Drops)
    • Uveitis
    • Other Retinal Disorders
  • Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
    • Lubricants and Emollients
    • Antihistamines
    • Mast Cell Stabilizers
    • Corticosteroids
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Prostaglandin Analogs
    • Beta-Blockers
    • Alpha Agonists
    • Carbonic Anhydrase Inhibitors
    • Antibiotics
    • Antivirals
    • Antifungals
    • Vasoconstrictors
    • Combination Drugs
  • Preservative Status Insights (Revenue, USD Bn, 2020 - 2032)
    • Preserved Eye Drops
    • Preservative-Free Eye Drops
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Brand
    • Generics
  • Formulation Insights (Revenue, USD Bn, 2020 - 2032)
    • Solution
    • Suspension
    • Emulsion
  • Viscosity Insights (Revenue, USD Bn, 2020 - 2032)
    • Low Viscosity
    • Medium Viscosity
    • High Viscosity
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Ophthalmology Clinics
    • Others (Ambulatory Surgery Centers)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Alcon
    • AbbVie Inc (Allergan)
    • Bausch Health Companies Inc
    • Johnson & Johnson Vision
    • Santen Pharmaceutical Co Ltd
    • Pfizer Inc
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd
    • Otsuka Pharmaceutical Co Ltd
    • Rohto Pharmaceutical Co Ltd
    • Thea Pharma Inc
    • Similasan Corporation
    • Akorn Operating Company LLC
    • Prestige Consumer Healthcare Inc
    • Jamjoom Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Eye Drops Market, By Type
    • Global Eye Drops Market, By Therapeutic Application
    • Global Eye Drops Market, By Drug Class
    • Global Eye Drops Market, By Preservative Status
    • Global Eye Drops Market, By Type
    • Global Eye Drops Market, By Formulation
    • Global Eye Drops Market, By Viscosity
    • Global Eye Drops Market, By Distribution Channel
    • Global Eye Drops Market, By End User
    • Global Eye Drops Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Eye Drops Market, By Therapeutic Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dry Eye Disease (DED) Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allergic Conjunctivitis Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Glaucoma & Ocular Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Eye Infection Treatment (Bacterial, Viral, Fungal)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Inflammation or Post-Surgical Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mydriasis or Cycloplegia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Dye Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post-Operative Care (Anesthetic Drops)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Retinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Eye Drops Market, By Drug Class, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lubricants and Emollients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antihistamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mast Cell Stabilizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prostaglandin Analogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Beta-Blockers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Alpha Agonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Carbonic Anhydrase Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antivirals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antifungals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Vasoconstrictors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Combination Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Eye Drops Market, By Preservative Status, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Preserved Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Preservative-Free Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Brand
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Generics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Eye Drops Market, By Formulation, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Emulsion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Eye Drops Market, By Viscosity, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Low Viscosity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medium Viscosity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • High Viscosity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Eye Drops Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Eye Drops Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ophthalmology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Ambulatory Surgery Centers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Eye Drops Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

14. Competitive Landscape

  • Alcon
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc (Allergan)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch Health Companies Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Vision
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Santen Pharmaceutical Co Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Rohto Pharmaceutical Co Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thea Pharma Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Similasan Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akorn Operating Company LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Prestige Consumer Healthcare Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jamjoom Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

15. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

16. References and Research Methodology

  • References
  • Research Methodology
  • About us